0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Targeting the DNA Damage Response for Anti-Cancer Therapy (Hardcover, 1st ed. 2018) Loot Price: R6,957
Discovery Miles 69 570
Targeting the DNA Damage Response for Anti-Cancer Therapy (Hardcover, 1st ed. 2018): John Pollard, Nicola Curtin

Targeting the DNA Damage Response for Anti-Cancer Therapy (Hardcover, 1st ed. 2018)

John Pollard, Nicola Curtin

Series: Cancer Drug Discovery and Development

 (sign in to rate)
Loot Price R6,957 Discovery Miles 69 570 | Repayment Terms: R652 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Over the past decade a complex role for DNA damage response (DDR) in tumorigenesis has emerged. A proficient DDR has been shown to be a primary cause for cellular resistance to the very many DNA damaging drugs, and IR, that are widely used as standard-of-care across multiple cancer types. It has also been shown that defects in this network, predominantly within the ATM mediated signaling pathway, are commonly observed in cancers and may be a primary event during tumorigenesis. Such defects may promote a genomically unstable environment, facilitating the persistence of mutations, any of which may provide a growth or survival advantage to the developing tumor. In addition, these somatic defects provide opportunities to exploit a reliance on remaining repair pathways for survival, a process which has been termed synthetic lethality. As a result of all these observations there has been a great interest in targeting the DDR to provide anti-cancer agents that may have benefit as monotherapy in cancers with high background DNA damage levels or as a means to increase the efficacy of DNA damaging drugs and IR. In this book we will review a series of important topics that are of great interest to a broad range of academic, industrial and clinical researchers, including the basic science of the DDR, its role in tumorigenesis and in dictating response to DNA damaging drugs and IR. Additionally, we will focus on the several proteins that have been targeted in attempts to provide drug candidates, each of which appear to have quite distinct profiles and could represent very different opportunities to provide patient benefit.

General

Imprint: Birkhauser Verlag AG
Country of origin: Switzerland
Series: Cancer Drug Discovery and Development
Release date: June 2018
First published: 2018
Editors: John Pollard • Nicola Curtin
Dimensions: 235 x 155mm (L x W)
Format: Hardcover
Pages: 401
Edition: 1st ed. 2018
ISBN-13: 978-3-319-75834-3
Categories: Books > Medicine > Clinical & internal medicine > Gene therapy
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 3-319-75834-9
Barcode: 9783319758343

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Kanker Schmanker!
Madelein Rust Paperback R320 R275 Discovery Miles 2 750
Problem Solving in Interventional…
Tze Wah Paperback R1,292 Discovery Miles 12 920
The Cancer Diet Cookbook - Comforting…
Dionne Detraz Paperback R516 R426 Discovery Miles 4 260
The Biology of Cancer
Robert A. Weinberg Paperback R1,805 R1,609 Discovery Miles 16 090
Never Ever Give Up - The Inspiring Story…
Erik Rees Paperback R431 R358 Discovery Miles 3 580
Handbook for the management of breast…
Jenny Edge, Ines Buccimazza Paperback R290 R268 Discovery Miles 2 680
The Caregiver's Guide to Cancer…
Victoria Landes Paperback R450 R378 Discovery Miles 3 780
Knowledge Beats Cancer
Albert Stegmann Alberts, Stegman Alberts, Alberts Paperback R320 R295 Discovery Miles 2 950
Kennis Klop Kanker
Albert Stegmann Alberts, Stegman Alberts, Alberts Paperback R320 R295 Discovery Miles 2 950
Coping Successfully with Prostate Cancer
Tom Smith Paperback R240 Discovery Miles 2 400
My Best Worst Year - A Breast Cancer…
Alison Tucker Paperback R280 R224 Discovery Miles 2 240
TNM Classification of Malignant Tumours…
JD Brierley Paperback R1,141 Discovery Miles 11 410

See more

Partners